ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 3421 - 3435 of 5996 products
Zhejiang Hisun Partners with Seattle's IDRI on Treatment for Drug-Resistant TB
$5.00
Available
GSK Teams Up with Ali Health to Promote HPV Vaccine in China
$5.00
Available
Columbia China Building $150 Million Hospital in Jiaxing, China
$5.00
Available
South Korea's EDGC and China's GPBio Form Genomics Partnership
$5.00
Available
Samsung Bioepis Forms Novel Biologics JV with Takeda Pharma
$5.00
Available
Ascletis In-Licenses China Rights to an HCV Treatment from Medivir
$5.00
Available
Harbin Gloria, WuXi Biologics Sign $818 Million Deal for Ex-China Rights to PD-1 Candidate
$5.00
Available
Zai Lab Files for $115 Million IPO in the US
$5.00
Available
Lilly Asia Ventures Closes Fourth Fund with $450 Million
$5.00
Available
Shanghai Ankon Raises $100 Million to Market Pill-like Endoscopy Device
$5.00
Available
Shenzhen Royal Asset to Pay $33 Million for Fibrosis Candidates from Prometic
$5.00
Available
Zai Lab of Shanghai Plans $150 Million IPO in the US
$5.00
Available
Fosun and Shanghai Pharmas Competing for $700 Million Stake in US-based Arbor
$5.00
Available
Biocept Raises $2.2 Million from Ally Bridge; Plans China Expansion
$5.00
Available
Hong Kong Test Shows Efficacy of Early Cancer Liquid Biopsy Testing
$5.00
Available